Should you buy Fennec Pharmaceuticals (FENC)?
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
FENC currently trades below the base anchor, in the lower half of the engine methodology range.
Engine methodology range — mechanically derived from pipeline gate outputs + peer-multiple inputs. Not an analyst price target. JSON-LD emission gated pending counsel review.
What the engine is tracking
- Elite Rule Of 40 With Gaap Loss→Stable
- Single Product Concentration Risk↓Deteriorating
- Bullish Breakout Technical Setup→Stable
- +2 more pillars — see the Why tab for full reasoning
→ Full pillar scorecard with all 5 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Single Product Concentration Risk
Trip ifPEDMARK-related revenue concentration falls below 70% of total revenue, or a second supply source is established.
- P2Elite Rule Of 40 With Gaap Loss
Trip ifRule of 40 score falls below 40 for 2 consecutive quarters.
- P3Bullish Breakout Technical Setup
Trip ifPrice closes below the 200-day moving average for more than 5 consecutive trading days.
- P4Insider Selling And Concentration Flags
Trip ifNet insider selling exceeds 200,000 shares over a rolling 90-day period.
- P5Gap To Analyst Target
Trip ifThe gap to the analyst target compresses below 10%, from the current 24.1%.
How the engine reached this verdict
TrendMatrix's engine output for Fennec Pharmaceuticals Inc. (FENC) is HOLD_IF_HOLDING with medium conviction, score 6.5/10 at $10.35. Bull and bear cases are roughly balanced; the engine output is HOLD because neither side cleared a positive-conviction threshold.
On the bear side: Concentration risk — Product: PEDMARK; Concentration risk — Supplier: third-party contract manufacturer (PEDMARK); Market cap $372M below $400M minimum. Active engine warnings: Market cap $372M below $400M minimum, V9 Gate Failed: MOMENTUM:2.9<4.5, V9 Gate Failed: INSIDER:0.38%=HEAVY.
The engine is not issuing fresh-money entry targets at the current verdict. The technical entry zone is around — with a technical stop near $9.71 for existing positions. Asymmetric R:R is 5.06, below the threshold (≥2.0) at which the engine would actively flag fresh capital. The engine's sizing output: AVOID at this asymmetry level (no fresh-capital deployment).
HOLD flips toward BUY_WAIT if momentum at 2.9 vs threshold 4.5 clears AND a co-confirming gate triggers. HOLD flips toward SELL if any of the currently-passing gates drop below threshold OR three or more dimensions fall below 4 simultaneously.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates FENC — 10-dimension breakdown →
Bear case
- ▸Concentration risk — Product: PEDMARK
- ▸Concentration risk — Supplier: third-party contract manufacturer (PEDMARK)
- ▸Market cap $372M below $400M minimum